Moxifloxacin Oral, Injection Products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
| Minimum Inhibitory | Disk Diffusion | ||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacteriaceae | ≤2 | 4 | ≥8 | ≥19 | 16–18 | ≤15 |
Enterococcus faecalis | ≤1 | 2 | ≥4 | ≥18 | 15–17 | ≤14 |
Staphylococcus spp. | M100 standard is recognized | |||||
Haemophilus influenzae and | M100 standard is recognized | |||||
Streptococcus pneumoniae | M100 standard is recognized | |||||
Anaerobes | M100 standard is recognized | |||||
Yersinia pestis | ≤0.25 | - | - | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant